Abstract
Higher-risk myelofibrosis is a complex disease requiring individualized care. At JADPRO Live 2024, presenters reviewed pathophysiology, diagnosis, risk assessment, and symptom management strategies for myelofibrosis. They also explored treatment options for higher-risk myelofibrosis, balancing benefits and risks while considering patient preferences and goals.
